Zeitschrift fur Pneumologie

Scope & Guideline

Advancing Lung Health Through Innovative Research

Introduction

Welcome to the Zeitschrift fur Pneumologie information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of Zeitschrift fur Pneumologie, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageGerman
ISSN2731-7404
PublisherSPRINGER HEIDELBERG
Support Open AccessNo
Country-
Type-
Converge-
AbbreviationZ PNEUMOLOGIE / Z. Pneumologie
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressTIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY

Aims and Scopes

The journal "Zeitschrift für Pneumologie" focuses on advancing knowledge and research in the field of pulmonary medicine, addressing a broad spectrum of respiratory diseases and their management. Its aims encompass clinical, diagnostic, and therapeutic aspects of pneumology, with an emphasis on interdisciplinary approaches and the integration of innovative technologies.
  1. Pulmonary Disease Management:
    The journal emphasizes the diagnosis and treatment of various pulmonary diseases, including chronic obstructive pulmonary disease (COPD), asthma, lung cancer, and interstitial lung diseases. It aims to provide insights into current therapeutic strategies and emerging treatment modalities.
  2. Interdisciplinary Approaches:
    There is a strong focus on interdisciplinary collaboration in pneumology, integrating insights from fields such as cardiology, oncology, and infectious diseases to enhance patient care and outcomes.
  3. Health-related Quality of Life:
    Research on the psychosocial aspects of pulmonary diseases, including the impact on patients' quality of life and mental health, is a core area of interest, reflecting the growing recognition of the psychological dimensions of chronic illnesses.
  4. Innovation in Diagnostics and Technology:
    The journal is committed to exploring new diagnostic tools and methodologies, such as noninvasive imaging techniques and digital health innovations, that can improve the accuracy and efficiency of pulmonary disease diagnosis.
  5. Public Health and Environmental Impact:
    Research addressing the impact of environmental factors, such as air pollution and climate change, on respiratory health is a key component, highlighting the journal's commitment to public health advocacy.
Recent publications in the journal indicate several emerging themes that reflect current trends in pulmonary medicine. These themes illustrate the evolving landscape of research priorities, driven by advancements in technology, public health challenges, and a deeper understanding of the psychosocial aspects of lung diseases.
  1. Impact of COVID-19:
    The ongoing repercussions of the COVID-19 pandemic on both respiratory health and mental well-being have emerged as a significant theme, with increasing research on long COVID and its implications for lung health.
  2. Digital Health Innovations:
    There is a growing trend towards exploring digital health solutions, such as telemedicine and mobile health applications, that enhance patient management and treatment adherence in pneumology.
  3. Gender-specific Research:
    An increasing emphasis on gender and sex-specific differences in respiratory diseases is evident, reflecting a broader trend towards personalized medicine and tailored treatment approaches.
  4. Psychopneumology:
    The intersection of psychology and pneumology is gaining traction, with more studies focusing on the mental health aspects of pulmonary disease management and the role of psychological comorbidities.
  5. Environmental and Public Health Issues:
    Research addressing the effects of environmental factors, such as air quality and climate change, on respiratory health is becoming more prominent, indicating a shift towards a holistic view of pulmonary medicine.

Declining or Waning

While the journal continues to explore a wide range of topics in pneumology, certain themes appear to be declining in prominence. This may reflect shifts in research priorities or advancements in understanding that make some previously emphasized areas less central.
  1. Traditional Diagnostic Techniques:
    There seems to be a decreasing focus on conventional diagnostic methods such as basic radiography and traditional spirometry, as the field moves towards more advanced imaging and diagnostic technologies.
  2. Generalist Pneumology Topics:
    Papers focusing on broad, generalist topics within pneumology, without a specific disease or innovative approach, appear to be less frequent, suggesting a shift towards more specialized and targeted research.
  3. Basic Research in Lung Biology:
    There is a noted decline in publications centered on fundamental biological research regarding lung function and pathology, possibly being overshadowed by more clinical and applied research themes.

Similar Journals

EUROPEAN RESPIRATORY JOURNAL

Shaping the Future of Respiratory Care
Publisher: EUROPEAN RESPIRATORY SOC JOURNALS LTDISSN: 0903-1936Frequency: 12 issues/year

The EUROPEAN RESPIRATORY JOURNAL, published by EUROPEAN RESPIRATORY SOC JOURNALS LTD, is at the forefront of advancing knowledge in the fields of pulmonary and respiratory medicine. With its ISSN 0903-1936 and E-ISSN 1399-3003, this esteemed journal has established itself as a leading platform since its inception in 1988, currently converging towards 2024. Ranked in the Q1 category for both Medicine (miscellaneous) and Pulmonary and Respiratory Medicine in 2023, it stands as the 3rd of 155 journals in its field, reflecting an impressive 98th percentile Scopus ranking. The journal boasts a rigorous selection of peer-reviewed articles that encompass innovative research, clinical studies, and reviews, thereby enhancing the understanding and treatment of respiratory diseases. Although it does not currently offer an Open Access option, the journal remains crucial for researchers, clinicians, and healthcare professionals committed to improving respiratory health across Europe and beyond. Join a community dedicated to groundbreaking research and advancements in respiratory medicine.

Pulmonology

Exploring the frontiers of respiratory health and innovation.
Publisher: ELSEVIERISSN: 2531-0437Frequency: 6 issues/year

Pulmonology, an esteemed journal published by Elsevier, serves as a vital platform for advancing knowledge in the field of Pulmonary and Respiratory Medicine. Since its transition to Open Access in 2018, this journal has successfully fostered a global readership, allowing for unrestricted dissemination of cutting-edge research. With an impressive Scopus ranking of #8 out of 155 in its category and a notable 2023 Q1 status, Pulmonology consistently showcases high-quality studies and reviews that contribute to the understanding and treatment of respiratory disorders. Authors and readers alike benefit from its commitment to publish influential research that addresses contemporary challenges in lung health. By bridging the gap between theory and clinical practice, the journal paves the way for innovative practices in pulmonology, making it an indispensable resource for researchers, healthcare professionals, and students interested in this dynamic field.

Tuberkuloz ve Toraks-Tuberculosis and Thorax

Exploring critical insights in thoracic medicine.
Publisher: TURKISH ASSOC TUBERCULOSIS & THORAXISSN: 0494-1373Frequency: 4 issues/year

Tuberkuloz ve Toraks (Tuberculosis and Thorax) is a distinguished journal published by the TURKISH ASSOCIATION OF TUBERCULOSIS AND THORAX located in Turkey. Serving as a pivotal platform for researchers and practitioners in the fields of Critical Care, Intensive Care Medicine, and Pulmonary and Respiratory Medicine, this journal has been disseminating vital research since 2003 and is committed to advancing knowledge and clinical practices related to tuberculosis and thoracic diseases. Although currently not an Open Access publication, its relevance is underscored by its rankings within Scopus, including a Q3 category in Critical Care and Intensive Care Medicine and a Q4 in Pulmonary and Respiratory Medicine, reflecting its significant contributions to the academic community. With a mission to foster the exchange of innovative ideas and encourage rigorous scholarly discourse, Tuberkuloz ve Toraks plays an essential role in addressing pressing health challenges associated with respiratory ailments and remains an invaluable resource for researchers, health professionals, and students dedicated to improving outcomes in thoracic health.

Thoracic Research and Practice

Driving Innovation in Thoracic Health and Research
Publisher: AVESISSN: Frequency: 6 issues/year

Thoracic Research and Practice is an emerging open access journal published by AVES that aims to advance knowledge in the field of pulmonary and respiratory medicine. Launched in 2022, this journal aspires to provide a platform for innovative research, clinical practices, and advancements in thoracic health. With an E-ISSN of 2979-9139, it caters to a global audience while based in Turkey. Although it currently holds a Q4 category in the 2023 ranking within its field, the journal is dedicated to improving its standing through the inclusion of high-quality, original articles, systematic reviews, and case studies. As it converges years from 2023 to 2024, Thoracic Research and Practice invites researchers, professionals, and students to contribute valuable insights that aim to enhance patient outcomes and propel further exploration in this critical area of medicine.

BMC Pulmonary Medicine

Elevating the standards of pulmonary research and practice.
Publisher: BMCISSN: 1471-2466Frequency: 1 issue/year

BMC Pulmonary Medicine is a leading open access journal dedicated to the field of pulmonary and respiratory medicine, published by BMC since its inception in 2001. With an ISSN of 1471-2466, this journal plays a pivotal role in advancing knowledge and research dissemination in its field, maintaining a prominent position with a 2023 Scopus ranking of #65 out of 155 journals, placing it within the 58th percentile of the category. Based in the United Kingdom, it operates under a collaborative mission to provide unrestricted access to vital research, contributing to the global understanding of respiratory health issues. The journal is recognized for its commitment to high-quality, peer-reviewed research, as evidenced by its Q2 category designation in Pulmonary and Respiratory Medicine. BMC Pulmonary Medicine aims to foster innovation and scholarship among researchers, professionals, and students, making it an indispensable resource for anyone engaged in pulmonary research and practice. The journal, accessible to everyone, enables the dissemination of impactful research that can influence clinical practice and policy worldwide.

Jornal Brasileiro de Pneumologia

Advancing respiratory health through innovative research.
Publisher: SOC BRASILEIRA PNEUMOLOGIA TISIOLOGIAISSN: 1806-3713Frequency: 6 issues/year

Jornal Brasileiro de Pneumologia is a pivotal open-access journal in the field of Pulmonary and Respiratory Medicine, published by SOC BRASILEIRA PNEUMOLOGIA TISIOLOGIA. Established in 2004, this esteemed publication has become a significant platform for researchers, health professionals, and students in Brazil and beyond, facilitating the exchange of innovative ideas and vital research findings. The journal is indexed in Scopus and is recognized in the 2023 category quartiles as Q3, ranking 86 out of 155 in its field with a corresponding 44th percentile. This reflects its growing influence and commitment to advancing knowledge concerning respiratory health. With a mission to disseminate high-quality research, the journal aims to foster advancements in clinical practice and improve outcomes in pulmonary diseases, making it an essential resource for those dedicated to enhancing the quality of care in respiratory medicine. For those seeking comprehensive access to critical studies and reviews in this domain, the Jornal Brasileiro de Pneumologia remains an invaluable asset.

CHEST

Connecting researchers and practitioners for impactful healthcare solutions.
Publisher: ELSEVIERISSN: 0012-3692Frequency: 12 issues/year

CHEST is a premier journal published by Elsevier, focusing on the vital fields of cardiology, critical care, and pulmonary medicine. Established in 1970, this esteemed journal has continually provided authoritative research, reviews, and clinical studies, catering to a global audience of healthcare professionals, researchers, and students. With an impressive impact factor, CHEST ranks in the top quartile (Q1) across its core categories according to the latest Scopus metrics, securing its position as a leading resource within cardiology (Rank #16), pulmonary (Rank #9), and critical care (Rank #8). Published quarterly, it offers a wealth of knowledge essential for advancing understanding and improving patient outcomes in these critical areas of healthcare. Researchers and practitioners are encouraged to submit their work, contributing to the ongoing discourse that shapes innovative practices and policies in respiratory and cardiovascular health.

EXPERIMENTAL LUNG RESEARCH

Unveiling the Complexities of Respiratory Medicine
Publisher: TAYLOR & FRANCIS INCISSN: 0190-2148Frequency: 10 issues/year

EXPERIMENTAL LUNG RESEARCH, published by Taylor & Francis Inc, is a pivotal journal within the field of pulmonary and respiratory medicine, with its extensive coverage spanning from 1980 to 2024. The journal is indexed with ISSN 0190-2148 and E-ISSN 1521-0499, marking its commitment to disseminating high-quality research. With its Category Quartile rankings falling within Q3 in Clinical Biochemistry, Molecular Biology, and Pulmonary and Respiratory Medicine as of 2023, EXPERIMENTAL LUNG RESEARCH serves as a crucial platform for researchers and professionals seeking to explore innovative findings and advancements in lung physiology, pathology, and therapeutic approaches. Although currently not Open Access, it offers substantial insights through rigorous peer-reviewed articles that contribute significantly to the scientific community's understanding of respiratory health. With Scopus rankings reflecting its relevance within its categories, this journal attracts a diverse readership interested in advancing the field of lung research.

AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY

Connecting Discoveries to Clinical Impact in Respiratory Medicine
Publisher: AMER THORACIC SOCISSN: 1044-1549Frequency: 12 issues/year

The AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, published by the esteemed American Thoracic Society, is a premier platform dedicated to advancing knowledge in the fields of pulmonary and respiratory medicine, cell biology, and clinical biochemistry. With an impressive impact factor and recognition as a Q1 journal in multiple categories for 2023, it ranks among the top tier of scholarly publications, evidencing its influence and contribution to the scientific community. Since its inception in 1989, the journal has provided a critical forum for researchers and professionals to disseminate innovative findings and pivotal reviews, driving forward the frontiers of respiratory biology. While the journal currently operates under traditional access mechanisms, it seeks to bridge gaps in research by presenting high-quality articles that address vital health challenges. As a key resource for both established researchers and emerging scholars in molecular biology and respiratory science, this journal plays a pivotal role in shaping the future of respiratory health advancements.

Respiratory Investigation

Unlocking the future of respiratory health.
Publisher: ELSEVIERISSN: 2212-5345Frequency: 6 issues/year

Respiratory Investigation is a leading peer-reviewed journal published by Elsevier, dedicated to advancing the field of Pulmonary and Respiratory Medicine. Since its inception in 2012, the journal has grown to become a vital resource for researchers, clinicians, and students alike, providing a platform for high-quality research articles, reviews, and clinical studies. With a commendable impact factor and ranked in the Q2 category of Scopus' 2023 metrics, it stands at rank #57 out of 155 in its field, illustrating its importance and influence within the academic community. Although the journal operates on a subscription basis, it remains committed to disseminating essential findings that enhance the understanding and treatment of respiratory diseases. Set against the innovative backdrop of the Netherlands, Respiratory Investigation not only serves as a conduit for scholarly exchange but also plays a critical role in shaping future research directions and clinical practices.